Usual Adult Dose for Crohn's Disease -- Maintenance:
300 mg IV over 30 minutes at Week 0, 2, and 6 and then every 8 weeks thereafter
Usual Adult Dose for Ulcerative Colitis:
300 mg IV over 30 minutes at Week 0, 2, and 6 and then every 8 weeks thereafter
Comments:
-Prior to initiating therapy, patients should be brought up to date with all immunizations according to current immunization guidelines.
-Discontinue if no evidence of therapeutic benefit by Week 14.
Uses:
-Adult Ulcerative Colitis (UC): Adults with moderately to severely active UC who have had an inadequate response with, lost response to, or were intolerant to a tumor necrosis factor (TNF) blocker or immunomodulator; or had an inadequate response with, were intolerant to, or demonstrated dependence on corticosteroids. This drug is used for inducing and maintaining clinical response or remission, improving endoscopic appearance of the mucosa, or achieving corticosteroid-free remission.
-Adult Crohn's Disease (CD): Adults with moderately to severely active CD who have had an inadequate response with, lost response to, or were intolerant to a TNF blocker or immunomodulator; or had an inadequate response with, were intolerant to, or demonstrated dependence on corticosteroids. This drug is used for achieving clinical response or remission or achieving corticosteroid-free remission.
 Detailed Entyvio dosage information
What happens if I miss a dose?
Call your doctor for instructions if you miss an appointment for your Entyvio injection.
What happens if I overdose?
Since this medicine is given by a healthcare professional in a medical setting, an overdose is unlikely to occur.
